Page last updated: 2024-08-24

1,2-distearoyllecithin and perflutren

1,2-distearoyllecithin has been researched along with perflutren in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kadowaki, N; Kodama, T; Maruyama, K; Namai, E; Oda, Y; Okada, N; Suzuki, R; Tachibana, K; Taira, Y; Utoguchi, N1

Other Studies

1 other study(ies) available for 1,2-distearoyllecithin and perflutren

ArticleYear
A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy.
    Journal of controlled release : official journal of the Controlled Release Society, 2009, Feb-10, Volume: 133, Issue:3

    Topics: Animals; Antigen Presentation; Antigens; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Survival; Cytotoxicity Tests, Immunologic; Dendritic Cells; Endocytosis; Fluorocarbons; Immunotherapy, Active; Interleukin-2; Liposomes; Mice; Mice, Inbred C57BL; Neoplasms; Ovalbumin; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Sodium Azide; Survival Analysis; T-Lymphocytes, Cytotoxic; Ultrasonics

2009